International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Journal
Overview
publication venue for
-
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
2024
-
Improved survival with combination chemotherapy and external beam radiation therapy in uterine carcinosarcoma..
32.
2022
-
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series..
32.
2022
-
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines..
32.
2022
-
Facilitated cascade testing (FaCT): a randomized controlled trial..
31.
2020
-
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients..
31.
2020
-
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study..
30.
2020
-
Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer..
30.
2020
-
Is hysterectomy necessary for the treatment of preinvasive stratified mucin producing intraepithelial lesions of the cervix?.
30.
2020
-
Multimodality adjuvant therapy and survival outcomes in stage I-IV uterine carcinosarcoma..
30.
2020
-
Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix..
30.
2020
-
Evolution and outcomes of sentinel lymph node mapping in vulvar cancer..
30.
2020
-
Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma..
29.
2019
-
Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors..
29.
2019
-
Factors influencing the adoption of the sentinel lymph node technique for endometrial cancer staging: an international survey of gynecologic oncologists..
29.
2019
-
Use of a Sentinel Lymph Node Biopsy Algorithm in a South African Population of Patients With Cervical Cancer and High Prevalence of Human Immunodeficiency Virus Infection..
28.
2018
-
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer..
28.
2018
-
Small Cell Carcinoma of the Ovary: A Rare Tumor With a Poor Prognosis..
28.
2018
-
Safety of Fertility-Sparing Surgery for Premenopausal Women With Sex Cord-Stromal Tumors Confined to the Ovary..
27.
2017
-
A Comparison of Outcomes Between Open Hysterectomy and Robotic-Assisted Hysterectomy for Endometrial Cancer Using the National Cancer Database..
27.
2017
-
A Comparison of the Detection of Sentinel Lymph Nodes Using Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye During Robotic Surgery in Uterine Cancer..
27.
2017
-
Epidemiology of Second Primary Tumors in Women With Ovarian Cancer..
27.
2017
-
A Comparison of Thermal Plasma Energy Versus Argon Beam Coagulator-Induced Intestinal Injury After Vaporization in a Porcine Model..
27.
2017
-
Pulmonary Resection in the Management of High-Risk Gestational Trophoblastic Neoplasia..
26.
2016
-
An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma..
26.
2016
-
A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer..
26.
2016
-
Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer..
25.
2015
-
Does death anxiety affect end-of-life care discussions?.
24.
2014
-
Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors..
24.
2014
-
Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer..
24.
2014
-
Quality of life, body mass index, and physical activity among uterine cancer patients..
24.
2014
-
Comparison of perioperative outcomes and complication rates between conventional versus robotic-assisted laparoscopy in the evaluation and management of early, advanced, and recurrent stage ovarian, fallopian tube, and primary peritoneal cancer..
24.
2014
-
Cancer-related concerns among women with a new diagnosis of gynecological cancer: an exploration of age group differences..
24.
2014
-
Cervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: is less enough?.
24.
2014
-
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)..
23.
2013
-
Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment..
23.
2013
-
Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation..
23.
2013
-
Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration..
23.
2013
-
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer..
23.
2013
-
Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters..
23.
2013
-
Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers..
23.
2013
-
Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009..
23.
2013
-
Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications..
23.
2013
-
Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution..
22.
2012
-
Sexual function of patients with endometrial cancer enrolled in the Gynecologic Oncology Group LAP2 Study..
22.
2012
-
Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience..
22.
2012
-
Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review..
22.
2012
-
Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival..
22.
2012
-
Identifying clinical improvement in consolidation single-arm phase 2 trials in patients with ovarian cancer in second or greater clinical remission..
22.
2012
-
The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?.
21.
2011
-
Recovery issues of fertility-preserving surgery in patients with early-stage cervical cancer and a model for survivorship: the physician checklist..
21.
2011
-
Pathologic analysis of ex vivo plasma energy tumor destruction in patients with ovarian or peritoneal cancer..
20.
2010
-
Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer..
20.
2010
-
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller..
20.
2010
-
Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population..
19.
2009
-
Indiana University experience in the management of vaginal cancer..
19.
2009
-
miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma..
19.
2009
-
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology..
18.
2008
-
Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery..
18.
2007
-
Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease..
18.
2007
-
Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening..
18.
2007
-
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance..
18.
2007
-
Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma..
17.
2007
-
A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer..
17.
2007
-
Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy..
17.
2007
-
Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study..
17.
2007
-
Resection of recurrent cervical cancer after total pelvic exenteration..
17.
2007
-
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer..
16.
2006
-
Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa..
16.
2006
-
p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas..
16.
2006
-
Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?.
16 Suppl 1.
2006
-
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy..
13.
2003
-
Presence and quantification of macrophages in squamous cell carcinoma of the cervix..
13.
2003
-
Topotecan for recurrent cervical cancer after platinum-based therapy..
10.
2000
-
Fulminant Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy..
9.
1999
-
Carboplatin and chlorambucil combination chemotherapy as treatment for patients with ovarian cancer..
4.
1994
-
The LACC Trial: Has Minimally Invasive Surgery for Early-Stage Cervical Cancer Been Dealt a Knockout Punch?.
28.
2018
-
Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.
2016
-
Improving response to progestin treatment of low-grade endometrial cancer.
2020
-
Current and novel mapping substances in gynecologic cancer care.
2020
-
Lower extremity lymphedema in patients with gynecologic malignancies.
2020
-
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
2014
-
Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.
2014
-
Ovarian cancer: the role of functional imaging as an end point in clinical trials.
2010
-
Cancer-related infertility in survivorship.
2010
-
Consolidation therapy in ovarian cancer: a clinical update.
2009
-
New agents for the treatment of ovarian cancer: the next generation.
2005
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)